The influence of health care policies and health care system distrust on willingness to undergo genetic testing

Medical Care

Volumn 50, Issue 5, 2012, Pages 381-387

  Armstrong, Katrina ^a,b   Putt, Mary ^a   Halbert, Chanita Hughes ^a,b   Grande, David ^a   Schwartz, Jerome Sanford ^a,b   Liao, Kaijun ^a   Marcus, Noora ^a   Demeter, Mirar Bristol ^a   Shea, Judy ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

distrust; genetic testing; health policy; racial disparities

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DEMOGRAPHY; ETHNIC OR RACIAL ASPECTS; FEMALE; GENERAL PRACTITIONER; GENETIC SCREENING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RATING SCALE; REVISED HEALTH CARE SYSTEM DISTRUST SCALE; SOCIAL ASPECT; SOCIAL MARKETING; STATISTICAL SIGNIFICANCE; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; ATTITUDE TO HEALTH; CONTINENTAL POPULATION GROUPS; DELIVERY OF HEALTH CARE; DISCLOSURE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC TESTING; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; INSURANCE, HEALTH; MALE; MEDICINE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; SOCIOECONOMIC FACTORS; TRUST; UNITED STATES; YOUNG ADULT;

EID: 84861589732     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0b013e31824d748b     Document Type: Article

References (53)

1. Hamburg MA, Collins FS. The path to personalized medicine. N Engl J Med. 2010;363:301-304.
2. Feero WG, Guttmacher AE, Collins FS. Genomic medicine-an updated primer. N Engl J Med. 2010;362:2001-2011.
3. Devilee P, Rookus MA. A tiny step closer to personalized risk prediction for breast cancer. N Engl J Med. 2010;362:1043-1045.
4. Gazdar AF. Personalized medicine and inhibition of EGFR signaling in lung cancer. N Engl J Med. 2009;361:1018-1020.
5. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol. 2003;21:2397-2406.
6. US Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med. 2005;143:355-361.
7. Recommendations from the EGAPP Working Group. Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med. 2009;11:35-41.
8. Available at: http://www.healthcare.gov/law/about/provisions/services/ background.html#cover. Accessed October 30, 2010.
9. Ku CS, Loy EY, Pawitan Y, et al. The pursuit of genome-wide association studies: where are we now? J Hum Genet. 2010;55:195-206.
10. Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med. 2010;363:166-176.
11. Olaya W, Esquivel P, Wong JH, et al. Disparities in BRCA testing: when insurance coverage is not a barrier. Am J Surg. 2009;198:562-565.
12. Suther S, Kiros GE. Barriers to the use of genetic testing: a study of racial and ethnic disparities. Genet Med. 2009;11:655-662.
13. Hall MJ, Olopade OI. Disparities in genetic testing: thinking outside the BRCA box. J Clin Oncol. 2006;24:2197-2203. (Pubitemid 46630692)
14. Shields AE, Burke W, Levy DE. Differential use of available genetic tests among primary care physicians in the United States: results of a national survey. Genet Med. 2008;10:404-414.
15. Armstrong K, Micco E, Carney A, et al. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA. 2005;293:1729-1736.
16. Susswein LR, Skrzynia C, Lange LA, et al. Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer. J Clin Oncol. 2008;26:32-36.
17. Halbert CH, Kessler L, Stopfer JE, et al. Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer. Genet Med. 2006;8:576-582. (Pubitemid 44402035)
18. Kaplan CP, Haas JS, Perez-Stable EJ, et al. Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups. Cancer Epidemiol Biomarkers Prev. 2006;15:162-166.
19. Zimmerman RK, Tabbarah M, Nowalk MP, et al. Racial differences in beliefs about genetic screening among patients at inner-city neighborhood health centers. J Natl Med Assoc. 2006;98:370-377. (Pubitemid 43352527)
20. Rose AL, Peters N, Shea JA, et al. Attitudes and misconceptions about predictive genetic testing for cancer risk. Community Genet. 2005;8: 145-151. (Pubitemid 41197097)
21. Peters N, Rose A, Armstrong K. The association between race and attitudes about predictive genetic testing. Cancer Epidemiol Biomarkers Prev. 2004;13:361-365. (Pubitemid 38737459)
22. Wideroff L, Vadaparampil ST, Breen N, et al. Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview Survey. Community Genet. 2003;6:147-156. (Pubitemid 38916113)
23. Pagan JA, Su D, Li L, et al. Racial and ethnic disparities in awareness of genetic testing for cancer risk. Am J Prev Med. 2009;37:524-530.
24. Armstrong K, McMurphy S, Dean LT, et al. Differences in the patterns of health care system distrust between blacks and whites. J Gen Intern Med. 2008;23:827-833.
25. Rajakumar K, Thomas SB, Musa D, et al. Racial differences in parents' distrust of medicine and research. Arch Pediatr Adolesc Med. 2009;163: 108-114.
26. Halbert CH, Weathers B, Delmoor E, et al. Racial differences in medical mistrust among men diagnosed with prostate cancer. Cancer. 2009;115: 2553-2561.
27. Carpenter WR, Godley PA, Clark JA, et al. Racial differences in trust and regular source of patient care and the implications for prostate cancer screening use. Cancer. 2009;115:5048-5059.
28. Armstrong K, Ravenell KL, McMurphy S, et al. Racial/ethnic differences in physician distrust in the United States. Am J Public Health. 2007;97:1283-1289. (Pubitemid 351182360)
29. Halbert CH, Armstrong K, Gandy OH Jr., et al. Racial differences in trust in health care providers. Arch Intern Med. 2006;166:896-901.
30. Voils CI, Oddone EZ,Weinfurt KP, et al.Who trusts healthcare institutions? Results from a community-based sample. Ethn Dis. 2005;15:97-103. (Pubitemid 40310059)
31. Phillips KA, Warner E, Meschino WS, et al. Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2. Clin Genet. 2000;57:376-383. (Pubitemid 30245824)
32. Lehmann LS, Weeks JC, Klar N, et al. A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing. Genet Med. 2002;4:346-352. (Pubitemid 44698548)
33. Brandt-Rauf SI, Raveis VH, Drummond NF, et al. Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic disease. Am J Public Health. 2006;96:1979-1988. (Pubitemid 44655923)
34. Institute of Medicine, Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academy of Sciences; 2003.
35. Armstrong K, Hughes-Halbert C, Asch DA. Patient preferences can be misleading as explanations for racial disparities in health care. Arch Intern Med. 2006;166:950-954.
36. Shea JA, Micco E, Dean LT, et al. Development of a revised Health Care System Distrust scale. J Gen Intern Med. 2008;23:727-732.
37. Green P, Srinivasan V. Conjoint analysis in marketing: new developments with implications for research and practice. J Mark. 1990;54:3-19.
38. Green P, Srinivasan V. Conjoint analysis in consumer research: issue outlook. J Consum Res. 1978;5:103-123.
39. Bhargava JS, Bhan-Bhargava A, Foss AJ, et al. Views of glaucoma patients on provision of follow-up care; an assessment of patient preferences by conjoint analysis. Br J Ophthalmol. 2008;92:1601-1605.
40. Bridges JF. Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. Appl Health Econ Health Policy. 2003;2:213-224.
41. Phillips KA, Johnson FR, Maddala T. Measuring what people value: a comparison of "attitude" and "preference" surveys. Health Serv Res. 2002;37:1659-1679. (Pubitemid 36070259)
42. Ryan M, Farrar S. Using conjoint analysis to elicit preferences for heath care (education and debate). BMJ. 2000;320:1530-1533. (Pubitemid 30330316)
43. Ryan M. A role for conjoint analysis in technology assessment in health care? Int J Technol Assess Health Care. 1999;15:443-457. (Pubitemid 29466178)
44. Bederman SS, Mahomed NN, Kreder HJ, et al. In the eye of the beholder: preferences of patients, family physicians, and surgeons for lumbar spinal surgery. Spine (Phila Pa 1976). 2010;35:108-115.
45. Fraenkel L, Chodkowski D, Lim J, et al. Patients' preferences for treatment of hepatitis C. Med Decis Making. 2010;30:45-57.
46. Sassi F, McDaid D, Ricciardi W. Conjoint analysis of preferences for cardiac risk assessment in primary care. Int J Technol Assess Health Care. 2005;21:211-218. (Pubitemid 40656550)
47. Green P, Wind J, Rao V. Conjoint Analysis: Methods and Application. Boca Raton, FL: CRC Press; 1999.
48. National Health Interview Survey Questionnaire. National Center for Health Statistics, 2001. Available http://www.cdc.gov/nchs/nhis/quest-data- related-1997-forward.htm. Accessed January 6, 2007.
49. Schafer JL. Analysis of incomplete multivariate data. London: Chapman & Hall; 1997.
50. Wilson T. Collecting conjoint data through telephone interviews. J Acad Mark Sci. 1984;12:190-199.
51. The American Association for Public Opinion Research. Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys. Lenexa, KS: The American Association for Public Opinion Research; 2004.
52. Armstrong K, Calzone K, Stopfer J, et al. Factors associated with decisions about clinical BRCA1/2 testing. Cancer Epidemiol Biomarkers Prev. 2000;9:1251-1254.
53. Foster MW, Eisenbraun AJ, Carter TH, et al. Genetic screening of targeted subpopulations: the role of communal discourse in evaluating sociocultural implications. Genet Test. 1997;1:269-274. (Pubitemid 128537151)